Back to School: How biopharma can reboot drug development. Access exclusive analysis here

FDA releases real-world evidence framework

FDA is creating a roadmap that will facilitate the integration of real-world evidence into drug development. FDA’s framework for real-world evidence envisions using data from electronic health records (EHRs), observational and pragmatic studies, and mobile or wearable devices to generate effectiveness data that would support approvals of new indications for approved drugs,

Read the full 521 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers